United States Biotechnology & Medical Research

Alumis Inc (ALMS)

Track

Track

Alumis Inc. experienced significant insider trading activity recently, characterized by substantial buying from Srinivas Akkaraju alongside smaller divestments by executives. Despite a 74.5% decline in share value over ninety days and a recent earnings report miss, net buying remains positive. These transactions occurred amidst high volatility following the company's August financial disclosure.
Ticker: ALMS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alumis Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
276.24
Quantity 11,318 -14.1%
Value US$590,788
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
232.57
Quantity 43,124 +49.7%
Value US$1,310,209
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Sale
Price
75.55
Quantity 8,472 +35.9%
Value US$300,205
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Sale
Price
10.55
Quantity 48,066 -1.0%
Value US$507,019
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
11.17
Quantity 220,070 +11.9%
Value US$2,458,842
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
11.17
Quantity 220,070 +4.9%
Value US$2,458,842
Pangali Sanam Chief Legal Officer Officer
Transaction date
Sale
Price
26.37
Quantity 1,364 -12.3%
Value US$35,969
Schroer John R. Chief Financial Officer Officer
Transaction date
Sale
Price
26.37
Quantity 3,282 -11.7%
Value US$86,546
Hardiman Roy C. Chief Business & Strategy Ofcr Officer
Transaction date
Planned sale
Price
26.37
Quantity 2,692 -1.3%
Value US$70,988
Goldstein David M Chief Scientific Officer Officer
Transaction date
Planned sale
Price
26.37
Quantity 2,596 -7.7%
Value US$68,457
Drappa Jorn Chief Medical Officer Officer
Transaction date
Sale
Price
26.37
Quantity 2,447 -4.1%
Value US$64,527
Bradley Mark Christopher Chief Development Officer Officer
Transaction date
Planned sale
Price
26.37
Quantity 2,572 -5.0%
Value US$67,824
Pangali Sanam Chief Legal Officer Officer
Transaction date
Sale
Price
28.00
Quantity 5,000 -31.0%
Value US$140,000
SANAMPREET PANGALI Officer Officer
Transaction date
Proposed sale
Price
28.00
Quantity 5,000
Value US$140,000
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 588,235 +46.5%
Value US$9,999,995
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 294,117 +11.3%
Value US$4,999,989
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 117,647 +2.1%
Value US$1,999,999
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 294,117 +11.3%
Value US$4,999,989
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 117,647 +2.1%
Value US$1,999,999
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
10.73
Quantity 51,380 +4.2%
Value US$551,307
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
10.01
Quantity 70,028 +6.1%
Value US$700,980
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
8.95
Quantity 64,969 +6.0%
Value US$581,473
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
8.18
Quantity 66,027 +6.5%
Value US$540,101
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
7.75
Quantity 100,000 +11.0%
Value US$775,000
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
7.55
Quantity 96,000 +11.8%
Value US$724,800
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
7.46
Quantity 86,350 +11.8%
Value US$644,171
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
7.64
Quantity 38,702 +5.6%
Value US$295,683
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
7.64
Quantity 48,537 +7.5%
Value US$370,823
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
7.38
Quantity 72,212 +2.8%
Value US$532,925
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.38
Quantity 72,212 +2.8%
Value US$532,925
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
7.20
Quantity 125,743 +24.3%
Value US$905,350
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.56
Quantity 190,500 +8.1%
Value US$1,249,680
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
6.56
Quantity 190,500 +8.1%
Value US$1,249,680
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
6.56
Quantity 137,772 +36.3%
Value US$903,784
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.19
Quantity 117,374 +5.3%
Value US$726,545
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
6.19
Quantity 117,374 +5.3%
Value US$726,545
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
6.05
Quantity 102,652 +37.0%
Value US$621,045
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.59
Quantity 150,000 +7.2%
Value US$838,500
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.60
Quantity 50,000 +2.5%
Value US$280,000
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
5.59
Quantity 150,000 +7.2%
Value US$838,500
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
5.60
Quantity 50,000 +2.5%
Value US$280,000
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
5.51
Quantity 914 +0.3%
Value US$5,036
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
5.25
Quantity 276,179 +inf%
Value US$1,449,940
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
4.34
Quantity 20,000 +0.5%
Value US$86,800
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
4.34
Quantity 20,000 +0.5%
Value US$86,800
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
5.27
Quantity 22,002 +0.6%
Value US$115,951
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
4.58
Quantity 138,368 +4.0%
Value US$633,725
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
4.62
Quantity 25,000 +0.6%
Value US$115,500
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
4.62
Quantity 25,000 +0.6%
Value US$115,500
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
4.55
Quantity 159,920 +4.9%
Value US$727,636
0.8
Colowick Alan Non-Executive Director
Transaction date
Purchase
Price
7.49
Quantity 2,300 +14.3%
Value US$17,235
0.5
Babler Martin President, CEO and Chairman Executive Director
Transaction date
Purchase
Price
6.44
Quantity 15,650 +17.2%
Value US$100,733
0.8
Colowick Alan Non-Executive Director
Transaction date
Purchase
Price
6.97
Quantity 16,104 +inf%
Value US$112,309
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 2,187,500 +108.6%
Value US$35,000,000
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 312,500 +5.9%
Value US$5,000,000
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 2,187,500 +108.6%
Value US$35,000,000
4.1
Foresite Labs, LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 312,500 +5.9%
Value US$5,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-08 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
11,318 -14.1%
276.24
US$590,788 		11,318 -14.1% 276.24 US$590,788
2026-09-09 2026-09-08 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
43,124 +49.7%
232.57
US$1,310,209 		43,124 +49.7% 232.57 US$1,310,209
2026-09-09 2026-09-08 S Sale
3.6
AKKARAJU SRINIVAS
Non-Executive Director
8,472 +35.9%
75.55
US$300,205 		8,472 +35.9% 75.55 US$300,205
2026-09-09 2026-09-08 S Sale
3.6
AKKARAJU SRINIVAS
Non-Executive Director
48,066 -1.0%
10.55
US$507,019 		48,066 -1.0% 10.55 US$507,019
2026-09-09 2026-09-04 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
220,070 +11.9%
11.17
US$2,458,842 		220,070 +11.9% 11.17 US$2,458,842
2026-09-09 2026-09-04 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
220,070 +4.9%
11.17
US$2,458,842 		220,070 +4.9% 11.17 US$2,458,842
2026-08-05 2026-08-03 S Sale
Pangali Sanam

Chief Legal Officer

Officer
1,364 -12.3%
26.37
US$35,969 		1,364 -12.3% 26.37 US$35,969
2026-08-05 2026-08-03 S Sale
Schroer John R.

Chief Financial Officer

Officer
3,282 -11.7%
26.37
US$86,546 		3,282 -11.7% 26.37 US$86,546
2026-08-05 2026-08-03 PlS Planned sale
Hardiman Roy C.

Chief Business & Strategy Ofcr

Officer
2,692 -1.3%
26.37
US$70,988 		2,692 -1.3% 26.37 US$70,988
2026-08-05 2026-08-03 PlS Planned sale
Goldstein David M

Chief Scientific Officer

Officer
2,596 -7.7%
26.37
US$68,457 		2,596 -7.7% 26.37 US$68,457
2026-08-05 2026-08-03 S Sale
Drappa Jorn

Chief Medical Officer

Officer
2,447 -4.1%
26.37
US$64,527 		2,447 -4.1% 26.37 US$64,527
2026-08-05 2026-08-03 PlS Planned sale
Bradley Mark Christopher

Chief Development Officer

Officer
2,572 -5.0%
26.37
US$67,824 		2,572 -5.0% 26.37 US$67,824
2026-07-08 2026-07-06 S Sale
Pangali Sanam

Chief Legal Officer

Officer
5,000 -31.0%
28.00
US$140,000 		5,000 -31.0% 28.00 US$140,000
2026-07-06 2026-07-06 PrS Proposed sale
SANAMPREET PANGALI

Officer

Officer
5,000
28.00
US$140,000 		5,000 28.00 US$140,000
2026-01-13 2026-01-09 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
588,235 +46.5%
17.00
US$9,999,995 		588,235 +46.5% 17.00 US$9,999,995
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
294,117 +11.3%
17.00
US$4,999,989 		294,117 +11.3% 17.00 US$4,999,989
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
117,647 +2.1%
17.00
US$1,999,999 		117,647 +2.1% 17.00 US$1,999,999
2026-01-12 2026-01-08 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
294,117 +11.3%
17.00
US$4,999,989 		294,117 +11.3% 17.00 US$4,999,989
2026-01-12 2026-01-08 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
117,647 +2.1%
17.00
US$1,999,999 		117,647 +2.1% 17.00 US$1,999,999
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
294,117 +11.3%
17.00
US$4,999,989 		294,117 +11.3% 17.00 US$4,999,989
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
117,647 +2.1%
17.00
US$1,999,999 		117,647 +2.1% 17.00 US$1,999,999
2025-12-09 2025-12-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
51,380 +4.2%
10.73
US$551,307 		51,380 +4.2% 10.73 US$551,307
2025-12-09 2025-12-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
70,028 +6.1%
10.01
US$700,980 		70,028 +6.1% 10.01 US$700,980
2025-12-09 2025-12-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
64,969 +6.0%
8.95
US$581,473 		64,969 +6.0% 8.95 US$581,473
2025-12-04 2025-12-04 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
66,027 +6.5%
8.18
US$540,101 		66,027 +6.5% 8.18 US$540,101
2025-12-04 2025-12-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
100,000 +11.0%
7.75
US$775,000 		100,000 +11.0% 7.75 US$775,000
2025-12-04 2025-12-02 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
96,000 +11.8%
7.55
US$724,800 		96,000 +11.8% 7.55 US$724,800
2025-12-01 2025-12-01 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
86,350 +11.8%
7.46
US$644,171 		86,350 +11.8% 7.46 US$644,171
2025-12-01 2025-11-28 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
38,702 +5.6%
7.64
US$295,683 		38,702 +5.6% 7.64 US$295,683
2025-12-01 2025-11-26 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
48,537 +7.5%
7.64
US$370,823 		48,537 +7.5% 7.64 US$370,823
2025-11-25 2025-11-21 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
72,212 +2.8%
7.38
US$532,925 		72,212 +2.8% 7.38 US$532,925
2025-11-25 2025-11-21 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
72,212 +2.8%
7.38
US$532,925 		72,212 +2.8% 7.38 US$532,925
2025-11-25 2025-11-21 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
72,212 +2.8%
7.38
US$532,925 		72,212 +2.8% 7.38 US$532,925
2025-11-24 2025-11-20 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
125,743 +24.3%
7.20
US$905,350 		125,743 +24.3% 7.20 US$905,350
2025-11-19 2025-11-19 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
190,500 +8.1%
6.56
US$1,249,680 		190,500 +8.1% 6.56 US$1,249,680
2025-11-19 2025-11-19 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
190,500 +8.1%
6.56
US$1,249,680 		190,500 +8.1% 6.56 US$1,249,680
2025-11-19 2025-11-19 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
190,500 +8.1%
6.56
US$1,249,680 		190,500 +8.1% 6.56 US$1,249,680
2025-11-19 2025-11-19 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
137,772 +36.3%
6.56
US$903,784 		137,772 +36.3% 6.56 US$903,784
2025-11-19 2025-11-18 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
117,374 +5.3%
6.19
US$726,545 		117,374 +5.3% 6.19 US$726,545
2025-11-19 2025-11-18 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
117,374 +5.3%
6.19
US$726,545 		117,374 +5.3% 6.19 US$726,545
2025-11-19 2025-11-18 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
117,374 +5.3%
6.19
US$726,545 		117,374 +5.3% 6.19 US$726,545
2025-11-19 2025-11-18 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
102,652 +37.0%
6.05
US$621,045 		102,652 +37.0% 6.05 US$621,045
2025-11-19 2025-11-17 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
150,000 +7.2%
5.59
US$838,500 		150,000 +7.2% 5.59 US$838,500
2025-11-19 2025-11-17 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
50,000 +2.5%
5.60
US$280,000 		50,000 +2.5% 5.60 US$280,000
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
150,000 +7.2%
5.59
US$838,500 		150,000 +7.2% 5.59 US$838,500
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
50,000 +2.5%
5.60
US$280,000 		50,000 +2.5% 5.60 US$280,000
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
150,000 +7.2%
5.59
US$838,500 		150,000 +7.2% 5.59 US$838,500
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
50,000 +2.5%
5.60
US$280,000 		50,000 +2.5% 5.60 US$280,000
2025-11-19 2025-11-17 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
914 +0.3%
5.51
US$5,036 		914 +0.3% 5.51 US$5,036
2025-11-17 2025-11-13 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
276,179 +inf%
5.25
US$1,449,940 		276,179 +inf% 5.25 US$1,449,940
2025-05-06 2025-05-06 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
20,000 +0.5%
4.34
US$86,800 		20,000 +0.5% 4.34 US$86,800
2025-05-06 2025-05-06 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
20,000 +0.5%
4.34
US$86,800 		20,000 +0.5% 4.34 US$86,800
2025-05-06 2025-05-06 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
20,000 +0.5%
4.34
US$86,800 		20,000 +0.5% 4.34 US$86,800
2025-05-06 2025-05-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
22,002 +0.6%
5.27
US$115,951 		22,002 +0.6% 5.27 US$115,951
2025-05-06 2025-05-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
138,368 +4.0%
4.58
US$633,725 		138,368 +4.0% 4.58 US$633,725
2025-05-06 2025-05-02 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
25,000 +0.6%
4.62
US$115,500 		25,000 +0.6% 4.62 US$115,500
2025-05-06 2025-05-02 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
25,000 +0.6%
4.62
US$115,500 		25,000 +0.6% 4.62 US$115,500
2025-05-06 2025-05-02 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
25,000 +0.6%
4.62
US$115,500 		25,000 +0.6% 4.62 US$115,500
2025-05-06 2025-05-02 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
159,920 +4.9%
4.55
US$727,636 		159,920 +4.9% 4.55 US$727,636
2025-04-03 2025-04-02 B Purchase
0.8
Colowick Alan
Non-Executive Director
2,300 +14.3%
7.49
US$17,235 		2,300 +14.3% 7.49 US$17,235
2025-04-03 2025-04-01 B Purchase
0.5
Babler Martin

President, CEO and Chairman

Executive Director
15,650 +17.2%
6.44
US$100,733 		15,650 +17.2% 6.44 US$100,733
2025-04-03 2025-04-01 B Purchase
0.8
Colowick Alan
Non-Executive Director
16,104 +inf%
6.97
US$112,309 		16,104 +inf% 6.97 US$112,309
2024-07-03 2024-07-01 B Purchase
3.5
Foresite Capital Management V, LLC
Large shareholder
2,187,500 +108.6%
16.00
US$35,000,000 		2,187,500 +108.6% 16.00 US$35,000,000
2024-07-03 2024-07-01 B Purchase
3.5
Foresite Capital Management V, LLC
Large shareholder
312,500 +5.9%
16.00
US$5,000,000 		312,500 +5.9% 16.00 US$5,000,000
2024-07-03 2024-07-01 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
2,187,500 +108.6%
16.00
US$35,000,000 		2,187,500 +108.6% 16.00 US$35,000,000
2024-07-03 2024-07-01 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
312,500 +5.9%
16.00
US$5,000,000 		312,500 +5.9% 16.00 US$5,000,000
2024-07-03 2024-07-01 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
2,187,500 +108.6%
16.00
US$35,000,000 		2,187,500 +108.6% 16.00 US$35,000,000
2024-07-03 2024-07-01 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
312,500 +5.9%
16.00
US$5,000,000 		312,500 +5.9% 16.00 US$5,000,000
Explore more

More insider trading research around Alumis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America